Icon

MYFEMBREE (nda214846)- (1MG;0.5MG;40MG)

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX SUMITOMO PHARMA
1MG;0.5MG;40MG
No No
2038-May-03 2025-Dec-18
None 2024-May-26
None No
MYFEMBREE is a combination of relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, estradiol, an estrogen, and norethindrone acetate, a progestin, indicated for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.
0 0 0
Total Other Developers 6
Drugs with Suitability No
1MG;0.5MG;40MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.